首页> Leukemia and lymphoma> Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy.

Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy.

导出原文传递

翻译打印收藏纠错

第一作者： Paschal BR

作者： Paschal BR ^[1]

作者单位： Asheville Hematology & Oncology Associates, PA., One Doctors Drive, Asheville, NC 28801, USA. ^[1]

关键词 Ontak denileukin diftitox Therapeutic procedure CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Leukemia and lymphoma

2003年44卷4期

731-733页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Leukemia and lymphoma

2003年44卷4期

731-733页

检索历史清除

Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy.

Leukemia and lymphoma

相似文献

同项目论文

Leukemia and lymphoma

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy.

Leukemia and lymphoma

相似文献

同项目论文

Leukemia and lymphoma

相关期刊

检索历史清除